Grants Awarded to Staff Members
| Academic Year | Grant Title and Investigators | Total Award Amount |
| 2021-2023 |
Motor Neuron Disease Association UK |
£150,000 |
| 2018-2020 | Health Research Board Dr. Deirdre Murray (PI) |
€213,894 |
| 2018-2020 | Health Research Board Dr. Bahman Nasserolesami (PI) |
€341,617 |
| 2018-2020 | Health Research Board Professor. Orla Hardiman (PI) |
€245,533 |
| 2018-2022 | Health Research Board Dr. Peter Bede (PI) |
€741,799 |
| 2018-2021 | Horizon 2020 TUDCA-ALS Professor Orla Hardiman |
€351,086 |
| 2018-2020 |
The ALS Association |
€160,545 |
| 2017-2023 | Science Foundation Ireland |
€126,809 |
| 2017-2018 | Health Research Board |
€19,968 |
| 2017-2020 | Irish Research Council: Government of Ireland Postgraduate Scholarship Award 2017 Ms Roisin Mc Mackin |
€60,500 |
| 2016-2018 | Department of Health and Human Services Centers for Disease Control and Prevention |
$800,000 |
| 2016-2018 | Science Foundation Ireland | €610,640 |
| 2016-2018 | The ALS Association | $199,984 |
| 2016-2018 | UK Motor Neurone Disease Association | £268,822 |
| 2016-2018 | Science Foundation Ireland & Trinity Foundation | €1,045,962 |
| 2016-2018 | UK Motor Neurone Disease Association | £75,125 |
| 2015-2016 | Health Research Board: Knowledge Exchange and Dissemination Scheme Awards 2015 | €59,972 |
| 2015-2017 | Irish Research Council: Government of Ireland Postdoctoral Fellowship 2015 Professor Orla Hardiman & Dr. Bahman Nasseroleslami |
€91,790 |
| 2014-2017 |
Health Research Board: Research Training Fellowship |
€350,000 |
| 2014-2017 | The Amyotrophic Lateral Sclerosis Association Professor Orla Hardimna (Co-PI) |
€240,000 |
| 2014-2017 | Joint Programme in Neurodegeneration (JPND) ALS-CarE Professor Orla Hardiman (Coordinator) |
€2.1million |
| 2013-2016 |
Health Research Board: Health Research Award (Biomarkers in Neurodegeneration) |
€330,000 |
| 2013-2015 |
The Amyotrophic Lateral Sclerosis Association: Post Doctoral Fellowship. |
$100,000 |
| 2013-2015 |
Thierry Latran Foundation: Post Doctoral Fellowship. |
€98,000 |
| 2013-2014 | Irish Institute of Clinical Neuroscience: Fellowship Grant in Clinical Neuroscience. Dr. Niall Pender (PI) |
€50,000 |
| 2012-2017 | Health Research Board: Clinician Scientist Award. Professor Orla Hardiman |
€800,000 |
| 2012-2015 | Health Research Board: Interdisciplinary Capacity Enhancement Award. Professor Orla Hardiman |
€625,000 |
| 2012-2015 | Workpackage leader SOPHIA: Joint Programme in Neurodegeneration (JPND) Biomarker Consortium €2.3m. Professor Orla Hardiman (PI) |
€232,000 |
| 2012 | Lundbeck Award: In Neurology, Psychiatry, Geriatrics. Professor Orla Hardiman |
€20,000 |
| 2011 | International Alliance of ALS/MND Forbes Norris Award. Professor Orla Hardiman |
|
| 2011-2016 | Workpackage leader EUROMOTOR European Community's Seventh Framework Programme under grant agreement n° [259867] Total €9.5 m. Professor Orla Hardiman |
€269,000 |
| 2011-2012 | Thierry Latran Award: Study of a novel TRH analogue in SOD1 mouse model of ALS. Dr. Julie Kelly (PI) Professor Orla Hardiman (Co-PI) |
€65,000 |
| 2010-2013 | Research Motor Neuron funding for Studentship in ALS Genetics. Professor Orla Hardiman |
€100,000 |
| 2010-2013 | USAMRAA: Evaluation of an acute RNAi-mediated therapeutic for visual dysfunction associated with traumatic brain injury. Dr. Colin Doherty (PI) |
$500,000 |
| 2009 | American Academy of Neurology/ALSA Sheila Essey Award in ALS Research. Professor Orla Hardiman |
$25,000 |
| 2009-2012 | Health Research Board-MRCG Research Awards: A pharmacogenomic study of chronic refractory epilepsy Brainwave – The Irish Epilepsy Association. Dr. Colin Doherty (Co-app) |
€147,675 |
| 2009-2012 | Health Research Board-MRCG Research Awards: PhD Programme in Neuropsyhcology UCD for neuropsychological endophenotypes in temporal lobe epilepsy. Brainwave – The Irish Epilepsy Association. Dr. Colin Doherty (Co-app) |
€90,000 |
| 2009-2010 | IMNDA Research Fellowship. Professor Orla Hardiman |
€50,000 |
| 2009-2010 | Irish Motor Neurone Disease Research Foundation: Determining Beneficial Effects of a New Therapeutic Compound, JAK4D, in the SOD1 Mouse Model of Amyotrophic Lateral Sclerosis (ALS). Dr. Julie Kelly (PI) |
€128,500 |
| 2008-2010 | DOH Innovation fund: Integrated care in Epilepsy. Dr. Colin Doherty (PI) |
€460,000 |
| 2008-2009 | IICN /Merck Serono Clinical Research. Professor Orla Hardiman |
€50,000 |
| 2007-2009 | Muscular Dystrophy USA. A WGA Study of ALS in a population Isolate.� Professor Orla Hardiman (PI) |
$533,000 |
| 2007-2008 | ALSA Initiation Grant: Population-based Epidemiology of Cognitive decline in ALS. Professor Orla Hardiman (PI) |
$80,000 |
| 2007-2012 | Health Research Board Clinician Scientist Award. Professor Orla Hardiman |
€1.7 million |
| 2007-2010 | Health Research Board Project Grant Replication and Development of WGA Study in an Irish ALS Population. Professor Orla Hardiman (PI) |
€350,000 |
| 2007-2010 | Enterprise Ireland CFTD/2006/122: Development of a Novel Compound for treating Neurological Disorders. Dr. Julie Kelly (PI) |
€392,415 |
| 2006-2007 | Enterprise Ireland PC/2005/201: Parenteral delivery system for first in class compound with Potential therapeutic application in CNS disorders. Dr. Julie Kelly (PI) |
€85,025 |
| 2005-2008 | Health Research Board: Project Grant RP/2005/152: Furthering the development of potent thyrotropin-releasing hormone-degrading ectoenzyme (TRH-DE inhibitors – toward a novel therapeutic strategy for CNS disorders. Dr. Julie Kelly (co-PI) |
€238,703 |
| 2005-2008 | Science Foundation Ireland Research Frontiers Programme 05/RFP/BIM0034: Exploration of methods to provide sustained expression of TRH peptide in a target tissue and investigation of neuroprotective properties of TRH. Dr. Julie Kelly (co-PI) |
€165,000 |
| 2005-2008 | Royal College of Surgeons in Ireland Funding: Mres/PhD programme for Imaging endophenotypes in Epilepsy: A new standard for associations. Dr. Colin Doherty (PI) |
€90,000 |
| 2005-2006 | Irish Epilepsy Association Grant: Genetic variation in the Gamma Aminobutyric Acid (GABA) system in patients with epilepsy: implications for pathophysiology and response to treatment. Dr. Colin Doherty (PI) |
€26,000 |
| 2004-2005 | International league against Epilepsy: Polymorphisms in Multi-Drug resistant Protein – Allelic Association Studies. Dr. Colin Doherty (PI) |
€10,000 |
| 2003-2012 | Higher Education Authority Programme for Research in Third Level Institutions (PRTLI) cycle 3 - Programme for Human Genomics (PHG) - Epilepsy Project. Dr. Colin Doherty (Co-PI) |
Industry Collaborations
| 2012 | Biogen Idec Heath Services study of ALS | €50,000 |